Haifa, Israel

Paula Berman

This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignees: Technion Research & Development Foundation Ltd, Tel Aviv University, Other. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paula Berman. Retrieved from https://idiyas.com/inventor/paula-berman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paula Berman: Innovator in Cannabinoid Research

Introduction

Paula Berman is a notable inventor based in Haifa, Israel. She has made significant contributions to the field of cannabinoid research, particularly in the development of pharmaceutical compositions that utilize cannabinoids for therapeutic purposes. Her work is particularly focused on treating diseases related to NOTCH 1.

Latest Patents

Paula Berman holds 1 patent for her invention titled "Cannabinoids and uses thereof." This patent provides a pharmaceutical composition that includes a combination of at least two cannabinoids, along with methods for using these compounds in medical treatments.

Career Highlights

Throughout her career, Paula has been associated with prominent institutions such as Technion Research & Development Foundation Ltd and Tel Aviv University. Her work at these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Paula has collaborated with esteemed colleagues, including Igal Louria-Hayon and Limor Broday. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Paula Berman's contributions to cannabinoid research highlight her role as an innovator in the pharmaceutical field. Her patent and collaborations reflect her commitment to advancing medical science through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…